Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.281, 2000-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Paclitaxel, doxorubicin regimen better for breast cancer
Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. :
Access to resources
Recommend
Liposomal doxorubicin effective for advanced breast cancer
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Weekly Paclitaxel in Elderly Patients with Advanced Breast Cancer: A Dose-Finding Study
By Repetto L.
Drugs in R&D, Vol. 5, Iss. 1, 2004-01 ,pp. :
Consider more than just economic factors in breast cancer care
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 330, 2001-01 ,pp. :